cro.directory
← Compare landing

iXCells Biotechnologies vs Nexus BioQuest

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryiXCells BiotechnologiesNexus BioQuest
SummaryOffers iPSC reprogramming, CRISPR genome editing, directed differentiation, and in vitro bioassay and ASO screening services. Builds human iPSC-derived cellular models for preclinical drug discovery.Nexus BioQuest is an immunology-focused CRO providing preclinical drug discovery and bespoke assay design services using human primary cells and patient material to support immune-therapeutic development across oncology, autoimmunity, and inflammation.
Services
  • Discovery Research
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • Discovery Research
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • Biomarker Assays
  • Translational Research
  • Immunology & Inflammation Services
Modalities
  • Oligonucleotide
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
Indications
  • Neurology
  • Oncology
  • Immunology
  • Neurology
Phases
  • Discovery
  • Preclinical (General)
  • Discovery
  • Preclinical (General)
Sourcing modelsData not yet provided.
  • Full-Service Outsourcing (FSO)
LocationsData not yet provided.
  • Headquarters, London, England, United Kingdom
CertificationsData not yet provided.Data not yet provided.

Find similar companies

iXCells Biotechnologies alternatives · Nexus BioQuest alternatives

Markdown mirror: /compare/ixcells-biotechnology/nexus-bioquest.md